TrialAdvances in therapy2026

Tislelizumab + Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-up.

Marcia Cruz-Correa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.